Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Total Cranial Vault Remodeling Using Multidirectional Cranial Distraction Osteogenesis in Craniosynostosis.

Plastic and reconstructive surgery. Global open·2026
Same author

Efficacy and safety of multimodality therapy stratified by resection rate and molecular markers in children and adolescents with ependymoma: JCCG EPN23 protocol.

Japanese journal of clinical oncology·2026
Same author

An Ultra-late Recurrence with Adenoid Cystic Carcinoma-like Malignant Transformation of a Pineal Immature Teratoma after 35 Years: A Case Report.

NMC case report journal·2026
Same author

BEND2 Immunohistochemistry as a Useful Diagnostic Marker for Astroblastomas With BEND2 Fusion.

The American journal of surgical pathology·2026
Same author

A pediatric case of anti-PF4 antibody-induced cerebral venous sinus thrombosis and thrombocytopenia following adenovirus infection: a literature review.

Brain & development·2025
Same author

Long-Term Outcomes of Radiation Therapy for Pediatric Brain Tumors: A Single-Center Study.

Cureus·2025

Related Experiment Video

Updated: Oct 3, 2025

Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy
03:13

Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy

Published on: June 28, 2024

860

[Precision Medicine for Ependymoma].

Akira Gomi1

  • 1Department of Pediatric Neurosurgery, Jichi Children's Medical Center Tochigi, Jichi Medical University.

No Shinkei Geka. Neurological Surgery
|February 16, 2022
PubMed
Summary
This summary is machine-generated.

Precision medicine for ependymoma is challenging due to few somatic mutations. Epigenetic mechanisms and novel gene fusions like ZFTA offer new therapeutic targets for treatment-resistant ependymoma subtypes.

More Related Videos

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.1K
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.9K

Related Experiment Videos

Last Updated: Oct 3, 2025

Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy
03:13

Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy

Published on: June 28, 2024

860
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.1K
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.9K

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Genetics

Background:

  • Ependymoma classification has evolved, revealing distinct molecular subgroups.
  • Certain ependymoma subtypes, including those with ZFTA fusion and MYCN amplification, exhibit resistance to conventional therapies.

Purpose of the Study:

  • To review current molecular classifications of ependymoma.
  • To explore molecular mechanisms driving ependymoma development and proliferation.
  • To identify potential precision medicine strategies for treatment-resistant ependymoma.

Main Methods:

  • Comprehensive literature review of molecular classifications, carcinogenesis studies, and therapeutic strategies for ependymoma.
  • Analysis of molecular mechanisms, including gene fusions and epigenetic alterations.
  • Identification of potential therapeutic targets based on molecular profiles.

Main Results:

  • Supratentorial ependymomas with ZFTA fusion, posterior fossa PFA group, and spinal ependymomas with MYCN amplification are identified as treatment-resistant and candidates for precision medicine.
  • Epigenetic mechanisms are implicated in the pathogenesis of PFA ependymomas lacking recurrent somatic mutations.
  • ZFTA forms various fusion genes, suggesting potential common therapeutic targets downstream of these fusions.

Conclusions:

  • Precision medicine for ependymoma faces challenges due to limited somatic mutations but is promising for specific molecular subtypes.
  • Epigenetic alterations and novel ZFTA fusion partners represent emerging targets for therapeutic development.
  • Further research is crucial to translate these molecular findings into clinical applications for ependymoma treatment.